295 related articles for article (PubMed ID: 32487466)
1. Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients.
Chwa WJ; Tishler TA; Raymond C; Tran C; Anwar F; Villablanca JP; Ventura J; Subotnik KL; Nuechterlein KH; Ellingson BM
Schizophr Res; 2020 Aug; 222():397-410. PubMed ID: 32487466
[TBL] [Abstract][Full Text] [Related]
2. Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics.
Wang C; Tishler TA; Nuechterlein KH; Ellingson BM
Psychiatry Res; 2023 Aug; 326():115364. PubMed ID: 37494877
[TBL] [Abstract][Full Text] [Related]
3. Accelerated longitudinal gray/white matter contrast decline in aging in lightly myelinated cortical regions.
Vidal-Piñeiro D; Walhovd KB; Storsve AB; Grydeland H; Rohani DA; Fjell AM
Hum Brain Mapp; 2016 Oct; 37(10):3669-84. PubMed ID: 27228371
[TBL] [Abstract][Full Text] [Related]
4. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
[TBL] [Abstract][Full Text] [Related]
5. The relationship between gray/white matter contrast and cognitive performance in first-episode schizophrenia.
Kobayashi H; Sasabayashi D; Takahashi T; Furuichi A; Kido M; Takayanagi Y; Noguchi K; Suzuki M
Cereb Cortex; 2024 Jan; 34(2):. PubMed ID: 38265871
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies.
Vita A; De Peri L; Deste G; Barlati S; Sacchetti E
Biol Psychiatry; 2015 Sep; 78(6):403-12. PubMed ID: 25802081
[TBL] [Abstract][Full Text] [Related]
7. Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder.
Jørgensen KN; Nerland S; Norbom LB; Doan NT; Nesvåg R; Mørch-Johnsen L; Haukvik UK; Melle I; Andreassen OA; Westlye LT; Agartz I
Psychol Med; 2016 Jul; 46(9):1971-85. PubMed ID: 27049014
[TBL] [Abstract][Full Text] [Related]
8. Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics.
Tishler TA; Bartzokis G; Lu PH; Raven EP; Khanoyan M; Kirkpatrick CJ; Pyle MH; Villablanca JP; Altshuler LL; Mintz J; Ventura J; Casaus LR; Subotnik KL; Nuechterlein KH; Ellingson BM
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):454-462. PubMed ID: 29735155
[TBL] [Abstract][Full Text] [Related]
9. Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [
Selvaraj S; Bloomfield PS; Cao B; Veronese M; Turkheimer F; Howes OD
Schizophr Res; 2018 May; 195():206-214. PubMed ID: 28893493
[TBL] [Abstract][Full Text] [Related]
10. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
[TBL] [Abstract][Full Text] [Related]
11. Absence of negative associations of insular and medial frontal gray matter volume with dissociative symptoms in schizophrenia.
Tseng HH; Chiu CD; Chen KC; Lee IH; Chen PS; Yang YK
J Psychiatr Res; 2021 Jun; 138():485-491. PubMed ID: 33965737
[TBL] [Abstract][Full Text] [Related]
12. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
Emsley R; Asmal L; du Plessis S; Chiliza B; Phahladira L; Kilian S
Psychol Med; 2017 Sep; 47(12):2187-2196. PubMed ID: 28347393
[TBL] [Abstract][Full Text] [Related]
13. Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis.
Ansell BR; Dwyer DB; Wood SJ; Bora E; Brewer WJ; Proffitt TM; Velakoulis D; McGorry PD; Pantelis C
Psychol Med; 2015 Feb; 45(3):515-27. PubMed ID: 25077698
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the corpus callosum in chronic schizophrenia treated with clozapine or risperidone and those never-treated.
Tao B; Xiao Y; Cao H; Zhang W; Yang C; Lencer R; Gong Q; Lui S
BMC Psychiatry; 2021 Oct; 21(1):538. PubMed ID: 34715831
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.
Bustillo JR; Jones T; Qualls C; Chavez L; Lin D; Lenroot RK; Gasparovic C
J Affect Disord; 2019 Mar; 246():745-753. PubMed ID: 30623820
[TBL] [Abstract][Full Text] [Related]
16. Alteration of gray matter microstructure in schizophrenia.
Seitz J; Rathi Y; Lyall A; Pasternak O; Del Re EC; Niznikiewicz M; Nestor P; Seidman LJ; Petryshen TL; Mesholam-Gately RI; Wojcik J; McCarley RW; Shenton ME; Koerte IK; Kubicki M
Brain Imaging Behav; 2018 Feb; 12(1):54-63. PubMed ID: 28102528
[TBL] [Abstract][Full Text] [Related]
17. Cortical gray-white matter contrast abnormalities in male children with attention deficit hyperactivity disorder.
Wang C; Shen Y; Cheng M; Zhu Z; Lv Y; Zhang X; Feng Z; Yang Z; Zhao X
Front Hum Neurosci; 2023; 17():1303230. PubMed ID: 38188507
[TBL] [Abstract][Full Text] [Related]
18. Disrupted structural covariance network in first episode schizophrenia patients: Evidence from a large sample MRI-based morphometric study.
Zhang X; Liu W; Guo F; Li C; Wang X; Wang H; Yin H; Zhu Y
Schizophr Res; 2020 Oct; 224():24-32. PubMed ID: 33203611
[TBL] [Abstract][Full Text] [Related]
19. Graph-Theory-Based Degree Centrality Combined with Machine Learning Algorithms Can Predict Response to Treatment with Antipsychotic Medications in Patients with First-Episode Schizophrenia.
Liu W; Fang P; Guo F; Qiao Y; Zhu Y; Wang H
Dis Markers; 2022; 2022():1853002. PubMed ID: 36277973
[TBL] [Abstract][Full Text] [Related]
20. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
Anderson VM; Goldstein ME; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
